Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Apo Flurazepam
2. Apo-flurazepam
3. Dalmadorm
4. Dalmane
5. Dihydrochloride, Flurazepam
6. Dormodor
7. Flurazepam
8. Flurazepam Dihydrochloride
9. Flurazepam Mono Perchlorate
10. Flurazepam Mono-perchlorate
11. Flurazepam Monohydrochloride
12. Hydrochloride, Flurazepam
13. Mono-perchlorate, Flurazepam
14. Monohydrochloride, Flurazepam
15. Staurodorm
1. Flurazepam Dihydrochloride
2. 1172-18-5
3. Dalmane
4. Dalmadorm
5. Dalmate
6. Felison
7. Linzac
8. Natam
9. Nsc-78559
10. Ro 5-6901
11. Insumin Dihydrochloride
12. 2h-1,4-benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-, Dihydrochloride
13. Flurazepam Hydrochloride Civ
14. Id 480
15. 756rdm536m
16. 7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one Dihydrochloride
17. Ro-5-6901
18. Benozil
19. Lunipax
20. Somlan
21. 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3h-1,4-benzodiazepin-2-one;dihydrochloride
22. Dea No. 2767
23. Einecs 214-630-0
24. Unii-756rdm536m
25. Dalmane (tn)
26. Flurazepam Hydrochloride [usan:usp:jan]
27. Schembl29792
28. Chebi:5129
29. Flurazepam Hydrochloride (usp)
30. Chembl3989724
31. Dtxsid3025334
32. Flurazepam Dihydrochloride, Solid
33. Flurazepam Hydrochloride [jan]
34. Flurazepam Dihydrochloride [mi]
35. Flurazepam Hydrochloride [usan]
36. Flurazepam Hydrochloride [vandf]
37. Flurazepam Hydrochloride [who-dd]
38. 2h-1,4-benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-, 1,3-dihydro-, Dihydrochloride
39. Flurazepam Dihydrochloride [mart.]
40. Db-041356
41. Flurazepam Hydrochloride Civ [usp-rs]
42. Flurazepam Hydrochloride [orange Book]
43. D00695
44. Flurazepam Hydrochloride [usp Monograph]
45. W-108568
46. Q27266355
47. Flurazepam Dihydrochloride, Drug Standard, 1.0 Mg/ml In Methanol
48. Flurazepam Hydrochloride, United States Pharmacopeia (usp) Reference Standard
49. 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one, Dihydrochloride
Molecular Weight | 460.8 g/mol |
---|---|
Molecular Formula | C21H25Cl3FN3O |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 459.104724 g/mol |
Monoisotopic Mass | 459.104724 g/mol |
Topological Polar Surface Area | 35.9 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 540 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Flurazepam hydrochloride |
Drug Label | Flurazepam hydrochloride is chemically 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluoro-phenyl)-1,3dihydro-2H-1,4-benzodiazepin-2-one dihydrochloride. It is a pale yellow, crystalline compound, freely soluble in alcohol and very soluble in water. It ha... |
Active Ingredient | Flurazepam hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 30mg; 15mg |
Market Status | Prescription |
Company | Mylan Pharms |
2 of 2 | |
---|---|
Drug Name | Flurazepam hydrochloride |
Drug Label | Flurazepam hydrochloride is chemically 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluoro-phenyl)-1,3dihydro-2H-1,4-benzodiazepin-2-one dihydrochloride. It is a pale yellow, crystalline compound, freely soluble in alcohol and very soluble in water. It ha... |
Active Ingredient | Flurazepam hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 30mg; 15mg |
Market Status | Prescription |
Company | Mylan Pharms |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
GABA Modulators
Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
ABOUT THIS PAGE
A Flurazepam Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flurazepam Dihydrochloride, including repackagers and relabelers. The FDA regulates Flurazepam Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flurazepam Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flurazepam Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flurazepam Dihydrochloride supplier is an individual or a company that provides Flurazepam Dihydrochloride active pharmaceutical ingredient (API) or Flurazepam Dihydrochloride finished formulations upon request. The Flurazepam Dihydrochloride suppliers may include Flurazepam Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Flurazepam Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Flurazepam Dihydrochloride written confirmation (Flurazepam Dihydrochloride WC) is an official document issued by a regulatory agency to a Flurazepam Dihydrochloride manufacturer, verifying that the manufacturing facility of a Flurazepam Dihydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Flurazepam Dihydrochloride APIs or Flurazepam Dihydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Flurazepam Dihydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Flurazepam Dihydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Flurazepam Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flurazepam Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flurazepam Dihydrochloride GMP manufacturer or Flurazepam Dihydrochloride GMP API supplier for your needs.
A Flurazepam Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Flurazepam Dihydrochloride's compliance with Flurazepam Dihydrochloride specifications and serves as a tool for batch-level quality control.
Flurazepam Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Flurazepam Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flurazepam Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Flurazepam Dihydrochloride EP), Flurazepam Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flurazepam Dihydrochloride USP).
LOOKING FOR A SUPPLIER?